Biogen Inc. vs Johnson & Johnson — Stock Comparison
Q·Score Breakdown
7.5
Buy
Overall
7.1
Buy
Quality
Health
Growth
Valuation
Sentiment
BIIB
Clean balance sheet with low leverage (0.4× debt-to-equity).
JNJ
High-quality business with 26% return on equity and 22% profit margins.
⚠ earnings contracting 53% year-over-year.
Analyst Consensus
BUY
Target $212.51 (+10.8%)
29 analysts
BUY
Target $252.42 (+10.0%)
24 analysts
Fundamentals
BIIB
JNJ
20.6×
Trailing P/E
26.6×
12.0×
Forward P/E
18.1×
13.8%
Profit Margin
21.8%
78.7%
Gross Margin
68.0%
7.7%
ROE
26.4%
1.9%
Revenue Growth
9.9%
31.1%
Earnings Growth
-52.9%
0.16
Beta
0.33
—
Price / Book
—
$28.3B
Market Cap
$552.5B
$115 – $202
52-Week Range
$146 – $252
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load.